Cargando…

The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity

Cyclic adenosine monophosphate (cAMP) is a second messenger that relays a wide range of hormone responses. In this paper, we demonstrate that the nuclear pore component RanBP2 acts as a negative regulator of cAMP signaling through Epac1, a cAMP-regulated guanine nucleotide exchange factor for Rap. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Gloerich, Martijn, Vliem, Marjolein J., Prummel, Esther, Meijer, Lars A.T., Rensen, Marije G.A., Rehmann, Holger, Bos, Johannes L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115801/
https://www.ncbi.nlm.nih.gov/pubmed/21670213
http://dx.doi.org/10.1083/jcb.201011126
_version_ 1782206174224973824
author Gloerich, Martijn
Vliem, Marjolein J.
Prummel, Esther
Meijer, Lars A.T.
Rensen, Marije G.A.
Rehmann, Holger
Bos, Johannes L.
author_facet Gloerich, Martijn
Vliem, Marjolein J.
Prummel, Esther
Meijer, Lars A.T.
Rensen, Marije G.A.
Rehmann, Holger
Bos, Johannes L.
author_sort Gloerich, Martijn
collection PubMed
description Cyclic adenosine monophosphate (cAMP) is a second messenger that relays a wide range of hormone responses. In this paper, we demonstrate that the nuclear pore component RanBP2 acts as a negative regulator of cAMP signaling through Epac1, a cAMP-regulated guanine nucleotide exchange factor for Rap. We show that Epac1 directly interacts with the zinc fingers (ZNFs) of RanBP2, tethering Epac1 to the nuclear pore complex (NPC). RanBP2 inhibits the catalytic activity of Epac1 in vitro by binding to its catalytic CDC25 homology domain. Accordingly, cellular depletion of RanBP2 releases Epac1 from the NPC and enhances cAMP-induced Rap activation and cell adhesion. Epac1 also is released upon phosphorylation of the ZNFs of RanBP2, demonstrating that the interaction can be regulated by posttranslational modification. These results reveal a novel mechanism of Epac1 regulation and elucidate an unexpected link between the NPC and cAMP signaling.
format Online
Article
Text
id pubmed-3115801
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-31158012011-12-13 The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity Gloerich, Martijn Vliem, Marjolein J. Prummel, Esther Meijer, Lars A.T. Rensen, Marije G.A. Rehmann, Holger Bos, Johannes L. J Cell Biol Research Articles Cyclic adenosine monophosphate (cAMP) is a second messenger that relays a wide range of hormone responses. In this paper, we demonstrate that the nuclear pore component RanBP2 acts as a negative regulator of cAMP signaling through Epac1, a cAMP-regulated guanine nucleotide exchange factor for Rap. We show that Epac1 directly interacts with the zinc fingers (ZNFs) of RanBP2, tethering Epac1 to the nuclear pore complex (NPC). RanBP2 inhibits the catalytic activity of Epac1 in vitro by binding to its catalytic CDC25 homology domain. Accordingly, cellular depletion of RanBP2 releases Epac1 from the NPC and enhances cAMP-induced Rap activation and cell adhesion. Epac1 also is released upon phosphorylation of the ZNFs of RanBP2, demonstrating that the interaction can be regulated by posttranslational modification. These results reveal a novel mechanism of Epac1 regulation and elucidate an unexpected link between the NPC and cAMP signaling. The Rockefeller University Press 2011-06-13 /pmc/articles/PMC3115801/ /pubmed/21670213 http://dx.doi.org/10.1083/jcb.201011126 Text en © 2011 Gloerich et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Research Articles
Gloerich, Martijn
Vliem, Marjolein J.
Prummel, Esther
Meijer, Lars A.T.
Rensen, Marije G.A.
Rehmann, Holger
Bos, Johannes L.
The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity
title The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity
title_full The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity
title_fullStr The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity
title_full_unstemmed The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity
title_short The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity
title_sort nucleoporin ranbp2 tethers the camp effector epac1 and inhibits its catalytic activity
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115801/
https://www.ncbi.nlm.nih.gov/pubmed/21670213
http://dx.doi.org/10.1083/jcb.201011126
work_keys_str_mv AT gloerichmartijn thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT vliemmarjoleinj thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT prummelesther thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT meijerlarsat thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT rensenmarijega thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT rehmannholger thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT bosjohannesl thenucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT gloerichmartijn nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT vliemmarjoleinj nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT prummelesther nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT meijerlarsat nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT rensenmarijega nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT rehmannholger nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity
AT bosjohannesl nucleoporinranbp2tethersthecampeffectorepac1andinhibitsitscatalyticactivity